Common use of Offer Price    Recitals Clause in Contracts

Offer Price    Recitals. Offer to Purchase 1.1(f) Out-of-the-Money Company Option 6.11(b) Term Section Reference Parent Preamble Parent Charter Documents 4.2 Parent Common Stock 9.1 Patents 3.17(a) Payment Agent 2.8(a) Pension Plan 3.11(a) Person 9.1 Phoenix Technologies Recitals Proxy Statement 6.3(a) PTO 9.1 Recommendations 8.1(d) Registered Intellectual Property 3.17(a) Requisite Stockholder Approval 3.4 Returns 3.15(a) Schedule 14D-9 1.2(b) Schedule TO 1.1(f) SEC 9.1 Securities Act 9.1 Special Committee 9.1 Special Committee Financial Advisor 3.22 Superior Proposal 6.1(c) Surviving Corporation 2.1 Tax 9.1 Tender and Voting Agreement(s) Recitals Termination and Amendment Agreement Recitals Termination Fee Amount 8.4(b) Triggering Event 8.1(d) URLs 3.17(a) 401(k) Termination Date 6.12(a) AGREEMENT AND PLAN OF MERGER THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) is made and entered into as of July 23, 2002 by and among Synopsys, Inc., a Delaware corporation (“Parent”), Ferrite Acquisition Corp., a Delaware corporation and a wholly-owned subsidiary of Parent (“Merger Sub”), and inSilicon Corporation, a Delaware corporation (the “Company”). Unless otherwise defined herein, all capitalized terms used in this Agreement shall have the respective meanings ascribed thereto in Article IX hereof.

Offer Price    Recitals. Offer to Purchase 1.1(fConditions 1.1(b) Old Plans 6.9(c) Out-of-the-Money Company Option 6.11(bLicenses 3.21(j) Term Section Reference Parent Preamble Parent Charter Documents 4.2 Parent Common Stock 9.1 Patents 3.17(a) Payment Agent 2.8(a) Pension Plan 3.11(aPermits 3.13 Privacy Policy 3.25(b) Person 9.1 Phoenix Technologies Recitals Promissory Note 6.14(b) Proxy Statement 6.3(a3.9(b) PTO 9.1 Recommendations 8.1(d) Registered Intellectual Property 3.17(aRegulatory Condition 1.1(b) Requisite Stockholder Approval 3.4 Returns 3.15(a3.2(b) SEC Reports 3.7 Schedule 14D-9 1.2(b) Schedule TO 1.1(f1.1(h) SEC 9.1 Short Form Threshold 6.14(a) Specified Representations 1.1(b) Subsidiary Securities Act 9.1 Special Committee 9.1 Special Committee Financial Advisor 3.22 Superior Proposal 6.1(c3.6(d) Surviving Corporation 2.1 Tax 9.1 Tender and Voting Agreement(s2.1(a) Recitals Termination and Amendment Tail Policy 6.10(b) Term Section Reference Support Agreement Recitals Termination Date 7.1(c) Termination Fee Amount 8.4(b7.4(a) Triggering Event 8.1(dTop-Up Option 6.14(a) URLs 3.17(aTop-Up Option Shares 6.14(a) 401(kTop-Up Exercise Notice 6.14(d) Termination Top-Up Notice Date 6.12(a6.14(d) Top-Up Closing 6.14(d) Top-Up Notice Receipt 6.14(d) ACQUISITION AGREEMENT AND PLAN OF MERGER THIS ACQUISITION AGREEMENT AND PLAN OF MERGER (this “Agreement”) is made and entered into as of July 23June 3, 2002 2013 by and among Synopsysxxxxxxxxxx.xxx, Inc.inc., a Delaware corporation (“Parent”), Ferrite Excalibur Acquisition Corp., a Delaware corporation and a wholly-owned subsidiary of Parent (“Merger Sub”), and inSilicon CorporationExactTarget, Inc., a Delaware corporation (the “Company”). Unless otherwise defined herein, all All capitalized terms that are used in this Agreement but not defined herein shall have the respective meanings ascribed thereto in Article IX hereof.Annex A.

Offer Price    Recitals. Offer to Purchase 1.1(f1.2 Ordinary Agreement 4.12(f) Out-of-the-Money Company Option 6.11(bOutside Date 8.1(b)(i) Term Section Reference Parent Preamble Parent Charter Documents 4.2 Disclosure Letter Article V Parent Common Stock 9.1 Patents 3.17(aMaterial Adverse Effect 5.1 Parent Owned Shares 5.8 Paying Agent 3.3(a) Payment Fund 3.3(a) Permits 4.11 Person 9.3(j) Redx Transaction Documents Recitals Representatives 9.3(k) Rights Agent 2.8(a) Pension Plan 3.11(a) Person 9.1 Phoenix Technologies Recitals Proxy Statement 6.3(a) PTO 9.1 Recommendations 8.1(d) Registered Intellectual Property 3.17(a) Requisite Stockholder Approval 3.4 Returns 3.15(a3.6 Xxxxxxxx-Xxxxx Act 4.6(a) Schedule 14D-9 1.2(b1.3(b) Schedule TO 1.1(f1.2 SEC 1.1(b) SEC 9.1 Securities Act 9.1 Special Committee 9.1 Special Committee Financial Advisor 3.22 4.5(b) Shares Recitals Subsidiary 9.3(l) Superior Proposal 6.1(c9.3(m) Surviving Corporation 2.1 Takeover Laws 4.14 Tax 9.1 Tender and Voting Agreement(sReturn 9.3(n) Recitals Termination and Amendment Agreement Recitals Taxes 9.3(o) Termination Fee Amount 8.4(b8.3(b) Triggering Event 8.1(dTransaction Expenses 9.3(p) URLs 3.17(a) 401(k) Termination Date 6.12(aWillful and Material Breach 8.2(b) AGREEMENT AND PLAN OF MERGER THIS This AGREEMENT AND PLAN OF MERGER (this “Agreement”) is made and entered into ), dated as of July 23March 26, 2002 by and among Synopsys2023, Inc.between CONCENTRA BIOSCIENCES, LLC, a Delaware corporation limited liability company (“Parent”), Ferrite Acquisition Corp.CONCENTRA MERGER SUB, INC., a Delaware corporation and a wholly-owned subsidiary Subsidiary of Parent (“Merger Sub”)) and JOUNCE THERAPEUTICS, and inSilicon CorporationINC., a Delaware corporation (the “Company”). Unless otherwise defined herein, all capitalized terms used in this Agreement shall have the respective meanings ascribed thereto in Article IX hereof.